30 closest matches · ranked by relevance
Anxiety Disorder · Cognitive/Functional Effects · Colorectal Cancer
Primary: Disease-free Survival — 80.3; 73.9 percentage of participants — p=0.02
Colon Adenocarcinoma · Stage IIA Colon Cancer AJCC v7 · Stage IIB Colon Cancer AJCC v7
Primary: Disease-free Survival — 75.5; 77.4 percentage of patients
Colorectal Neoplasms · Peritoneal Neoplasms
Primary: Peritoneal Recurrence Free Survival at 18 Months — 79; 80 participants
Rectal Cancer · Cancer of the Rectum · Colorectal Cancer
Primary: Disease-Free Survival (DFS), The Proportion of Patients Predicted to be Alive Without Evidence of Disease Recurrence 24 Months After Completion of Protocol Treatment…
Colorectal Cancer
Primary: Disease-free Survival in Stage III Cancer Patients - Time to Event — NA; NA; NA months — p=0.2024
Colorectal Cancer
Primary: Pathologic Complete Response Rate — 25 percentage of participants — p=0.18
Colorectal Cancer (CRC)
Primary: Number of Participants Who Maintained an Exercise Regimen Average of 18 Metabolic Units (MET) Per Week or Greater — 18 participants
Adenocarcinoma of the Colon · Stage III Colon Cancer
Primary: Disease-free Survival (Arms A and D: Wild-type KRAS Patients) — 74.6; 71.5 percentage of participants
Rectal Mucinous Adenocarcinoma · Rectal Signet Ring Cell Adenocarcinoma · Recurrent Rectal Carcinoma
Primary: 3-year Overall Survival Rate — 0.965; 0.843; 0.870 proportion of patients — p=0.35
Colorectal Cancer
Primary: Disease-free Survival — 73.4; 76.3 percentage of participants — p=0.12
Esophageal Carcinoma
Primary: Pathologic Complete Response — 55 participants
Esophageal Cancer
Primary: Pathological Complete Response — 26 participants
Rectal Cancer
Primary: Pathologic Complete Response Rate — 7 participants
Colorectal Cancer
Primary: Major Morbidity Related to the Intact Primary Tumor — 16.3 probability of major morbidity (%)
Colorectal Cancer
Primary: 3-Year Disease-free Survival — 88.2 percentage of patients
Colorectal Cancer
Primary: Disease-free Survival — 656; 603 Participants — p=0.053
Recurrence
Primary: Recurrence — 10; 5; 24 Polyps
Recurrent Colon Cancer · Recurrent Rectal Cancer · Stage IV A Bladder Cancer
Primary: Detection of Position Accuracy With Handheld Probe on Anatomical Location. — 35; 8; 2 lesions
Breast Cancer
Primary: Acute Radiation Effects (Less Than 90 Days Post Treatment) — 0 Participants
Operation Finding · Complications · Pathology
Primary: Histopathological Outcomes Obtained Through the Surgeries — 20.3; 19.2 nodes
Esophageal Cancer
Primary: Complete Response — 27.78 percentage of patients
Colorectal Cancer
Primary: Disease-Free Survival (Time to Event) — 25 months
Postoperative Stage II/III Colon Cancer
Primary: The Cumulative Rates of Participants With NCI-CTCAE Grade 2 or Higher Peripheral Sensory Neuropathy: Up to End of Study Treatment — 11; 11; 18 Participants
Colorectal Cancer
Primary: The Percentage of Patients Experiencing Treatment-related Gastrointestinal Adverse Events ≥ Grade 2 Per National Cancer Institute (NCI) Common Terminology Criteria for…
Colorectal Cancer
Primary: Pathologic Response and Complete Response — 3 Participants
Adenocarcinoma of the Lower Rectum
Primary: Clinical Complete Response Rate — 36; 2 Participants
Colon Cancer · Neoadjuvant Therapy
Primary: Tumor Regression Rate of MSS/pMMR Patients — 7 Participants
Anal Cancer
Primary: 2 Year Failure Free Survival — 20 participants
Colorectal Cancer
Primary: Pathologic Complete Response Rate — 10.4; 20.8 percentage of participants
Rectal Cancer
Primary: Number of Participants With Disease Recurrence — 53; 39 Participants — p=0.047